These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6481731)

  • 1. Clinical and biochemical variables in RA patients on NSAID therapy.
    Surrall KE; Dixon JS
    J Rheumatol; 1984 Aug; 11(4):552-4. PubMed ID: 6481731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced remission in the severe progressive variant of rheumatoid arthritis].
    Krel' AA; Semenova OIu; Kanevskaia MZ; Shekhter AB
    Ter Arkh; 1994; 66(1):24-9. PubMed ID: 8146788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum gastrin in rheumatoid arthritis].
    Taglieri G; Piga M; Ibba G; Piras MR; Uras R
    Rev Rhum Mal Osteoartic; 1982 Jun; 49(7):533-5. PubMed ID: 7123127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic therapy of rheumatoid arthritis with delayed-action anti-rheumatic drugs].
    Saal JG
    Internist (Berl); 1993 Jan; 34(1):9-17. PubMed ID: 8440581
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
    Cervini C; Salaffi F; Peroni M
    Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracorporeal therapy of rheumatoid arthritis].
    Aseeva EA; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 2001; 73(6):70-5. PubMed ID: 11521529
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: how physicians manage treatment failures.
    Spencer-Green G; Spencer-Green E
    J Rheumatol; 1998 Nov; 25(11):2088-93. PubMed ID: 9818649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New perspectives in the treatment of rheumatoid arthritis].
    Guzmán L
    Rev Med Chil; 1993 Jul; 121(7):789-90. PubMed ID: 8296084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind study comparing benoxaprofen, aspirin, and benoxaprofen plus aspirin in patients with rheumatoid arthritis.
    Ridolfo AS; Ashbrook EM; Schmid GE; Vogel JA; Rockhold FW; Offen WW
    Eur J Rheumatol Inflamm; 1982; 5(2):239-45. PubMed ID: 7044799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term clinical follow-up studies of basic therapy in rheumatoid arthritis].
    Piaĭ LT
    Ter Arkh; 1981; 53(7):67-9. PubMed ID: 7292319
    [No Abstract]   [Full Text] [Related]  

  • 12. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
    Wolfe F; Hawley DJ
    J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
    Charles-Schoeman C; Khanna D; Furst DE; McMahon M; Reddy ST; Fogelman AM; Paulus HE; Park GS; Gong T; Ansell BJ
    J Rheumatol; 2007 Jul; 34(7):1459-64. PubMed ID: 17552046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy in rheumatoid arthritis.
    Emery P
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():21-3. PubMed ID: 8448632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis.
    De Zubiria RC; Charria A; Lobo Guerrero D
    Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serum hyaluronan and disease activity and severity in Thai patients with rheumatoid arthritis.
    Louthrenoo W; Kongtawelert P; Sivasomboon C; Sukitawut W
    J Med Assoc Thai; 2001 May; 84(5):622-7. PubMed ID: 11560209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996.
    Ward MM; Fries JF
    J Rheumatol; 1998 Mar; 25(3):408-16. PubMed ID: 9517756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of serum creatinine levels in patients of rheumatoid arthritis on long term NSAID therapy.
    Pathan E; Gaitonde S; Rajadhyaksha S; Sule A; Mittal G; Joshi VR
    J Assoc Physicians India; 2003 Nov; 51():1045-9. PubMed ID: 15260386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.